![Clinical Trials: The Ever-changing Face of Complexity](https://www.medidata.com/wp-content/uploads/2024/02/clinical-trials-the-ever-changing-face-of-complexity-768x512.jpg)
Clinical Trials Arena reports that Lexicon will work with Medidata to progress their Phase IIb of LX9211 study, leading to the first new drug to be approved for diabetic peripheral neuropathy in more than 20 years.
Clinical Trials Arena reports that Lexicon will work with Medidata to progress their Phase IIb of LX9211 study, leading to the first new drug to be approved for diabetic peripheral neuropathy in more than 20 years.